SHARE-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF RESTRICTED ORDINARY SHARES HELD BY THE COMPANY'S EMPLOYEES

A summary of the Company’s restricted ordinary shares held by the Company’s employees for the years ended December 31, 2021 and 2022 is presented below:

	Number of shares			Weighted average grant date fair value
Unvested as of January 1, 2021		5,436,595			1.32
Granted		8,309,677			4.65
Vested		(5,436,595	)		1.32
Forfeited		(295,000	)		3.19
Unvested as of December 31, 2021		8,014,677			4.71
Granted		3,822,089			0.66
Vested		(1,755,548	)		7.45
Forfeited		(5,104,733	)		2.21
Unvested as of December 31, 2022		4,976,485			3.20

SCHEDULE OF COMPENSATION EXPENSES RECOGNIZED

Total compensation expenses recognized for restricted ordinary shares for the years ended December 31, 2020, 2021 and 2022 were allocated to the following expense items:

	Year ended December 31,
	2020		2021		2022
	RMB		RMB		RMB
Research and development expenses		-		8,618		(5,158	)
General and administrative expenses		67,026		112,218		59,133
Selling and marketing expenses		-		4,191		1,275
Total restricted ordinary shares compensation expenses		67,026		125,027		55,250

SCHEDULE OF SHARE OPTIONS ACTIVITIES

	Number of shares			Weighted average exercise price		Weighted remaining contractual years		Aggregate intrinsic value
				US$				US$
Outstanding as of January 1, 2021		25,198,592			0.25
Granted		5,355,499			0.26
Forfeited		(1,754,969	)		0.30
Excercised		(6,729,352	)		0.26
Outstanding as of December 31, 2021		22,069,770			0.25
Forfeited		(755,960	)		0.34
Excercised		(3,718,773	)		0.25				7,160
Outstanding as of December 31, 2022		17,595,037			0.24
Vested and expected to vest as of December 31, 2022		17,595,037			0.24		4.66		30,507
Exercisable as of December 31, 2022		16,708,959			0.21		3.59		30,245

SCHEDULE OF FAIR VALUE ASSUMPTIONS

The fair values of the options granted are estimated on the dates of grant using the binomial option pricing model with the following assumptions used:

Grant dates:	2020			2021
Risk free rate of return		0.61%-1.88	%		1.06%-1.57	%
Volatility		48.21%-49.36	%		48.76%-49.21	%
Expected dividend yield		0	%		0	%
Exercise multiple		2.20			2.20
Fair value of underlying ordinary share		US$1.30- US$3.12			US$1.45- US$16.70
Expiration terms		10 years			10 years

Share-Based Payment Arrangement, Option [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF COMPENSATION EXPENSES RECOGNIZED

	RMB		RMB		RMB
	Year ended December 31,
	2020		2021		2022
	RMB		RMB		RMB
Cost of revenues		761		507		(621	)
Research and development expenses		909		9,946		(795	)
Selling and marketing expenses		3,467		16,960		(765	)
General and administrative expenses		25,132		109,530		54,393
Total share option compensation expenses		30,269		136,943		52,212